Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP‐1RA treatment: A subgroup analysis from the FIDELIO‐DKD trial

Author:

Rossing Peter12,Agarwal Rajiv3,Anker Stefan D.4,Filippatos Gerasimos5,Pitt Bertram6,Ruilope Luis M.789,Amod Aslam10,Marre Michel11,Joseph Amer12,Lage Andrea13,Scott Charlie14,Bakris George L.15ORCID,

Affiliation:

1. Steno Diabetes Center Copenhagen Gentofte Denmark

2. Department of Clinical Medicine University of Copenhagen Copenhagen Denmark

3. Richard L. Roudebush VA Medical Center and Indiana University Indianapolis Indiana USA

4. Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin Berlin Germany

5. Department of Cardiology National and Kapodistrian University of Athens, School of Medicine, Attikon University Hospital Athens Greece

6. Department of Medicine University of Michigan School of Medicine Ann Arbor Michigan USA

7. Cardiorenal Translational Laboratory and Hypertension Unit Institute of Research imas12 Madrid Spain

8. CIBER‐CV Hospital Universitario 12 de Octubre Madrid Spain

9. Faculty of Sport Sciences European University of Madrid Madrid Spain

10. Department of Diabetes and Endocrinology Life Chatsmed Garden Hospital and Nelson R. Mandela School of Medicine, University of KwaZulu‐Natal Durban South Africa

11. Clinique Ambroise Paré Neuilly‐sur‐Seine Centre de Recherches des Cordelier, Université Paris Diderot Paris France

12. Cardiology and Nephrology Clinical Development Bayer AG Berlin Germany

13. Cardiology and Nephrology Clinical Development Bayer SA São Paulo Brazil

14. Data Science and Analytics Bayer PLC Reading UK

15. Department of Medicine University of Chicago Medicine Chicago Illinois USA

Funder

Bayer

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3